Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,301.60
(
-1.70%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
2.42%
)
Bitcoin
79,029.01
(
-2.50%
)
News Focus
News Focus
Post# of 257577
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122987
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 125771

Tuesday, 10/18/2011 2:41:20 PM

Tuesday, October 18, 2011 2:41:20 PM

Post# of 257577
Appellate court upholds $442M award of patent-infringement damages against Apotex in generic-Plavix case:

http://www.bloomberg.com/news/2011-10-18/bristol-myers-sanofi-442-million-plavix-award-upheld-on-appeal.html

The amount would have been much higher if BMY/SNY and Apotex had not inked a side agreement limiting Apotex’s damages to 50% of the economic harm caused by the patent infringement (#msg-13046621, #msg-12797613).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today